Jenna Cohen | executive |
Kathryn Haviland | executive |
Philina Lee | executive |
Fouad Namouni | executive |
Michael Landsittel | executive |
Bradley Canino | analyst |
Christina Rossi | executive |
Salveen Richter | analyst |
Marc Frahm | analyst |
Reni Benjamin | analyst |
Michael Schmidt | analyst |
Becker Hewes | executive |
Derek Archila | analyst |
Laura Prendergast | analyst |
Rohit | analyst |
Matthew Biegler | analyst |
Ami Fadia | analyst |
Peter Lawson | analyst |
Colleen Hanley | analyst |
Good morning. My name is Drew, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions]. Thank you.